Searched for
TREATMENT FOR CVS
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
She vomited 15 times a day. It took doctors 2 years to diagnose her with rare neuroendocrine illness. What is Cyclic Vomiting Syndrome?Sharisse Zeroonian, a 29-year-old woman, endured years of unexplained vomiting, eventually diagnosed with cyclic vomiting syndrome (CVS). S...
Biocon Biologics secures multiple market access agreements in US for YesintekBiocon Biologics' Yesintek, a biosimilar to Stelara, has secured significant market access in the US, covering over 100 million lives. Mult...
Zydus Lifesciences joins hands with CVS Caremark for diabetes drugs template formularyZydus Lifesciences Ltd enters an agreement with CVS Caremark to add Zituvio, Zituvimet, and Zituvimet XR tablets for diabetes treatment to ...
Texas: 21 injured in gas explosion at hotel in Fort WorthIn an evening update, police reported one person in critical condition and four seriously injured. Of the injured, 14 were transported to a...
Amazon to start testing drones for doorstep delivery of medicationsThe drone, programed to fly from a delivery center with a secure pharmacy, will travel to the customer's address, descend to a height of ab...
US pharmacy chains to pay $10 bn to settle opioid casesUS pharmacy chains CVS Health and Walgreens said Wednesday they had reached preliminary agreements to together pay more than $10 billion to...
Covid pills are here, but they aren't for everyone. Find out if you should take this medicationThe pills have to be started as soon as possible, within five days of the start of symptoms.
Govt to come up with financial assistance for fighting rare diseasesThe decision comes as the government comes up with a new draft policy for the treatment of rare diseases, more than a year after it withdre...
Aurobindo Pharma gets USFDA nod for Levofloxacin injectionAurobindo Pharma today said it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Levoflo...
Intas launches cheaper generic blood cancer drugIntas is manufacturing Azadine at its Ahmedabad facility, which operates in compliance with global regulatory standards like USFDA, MHRA an...
Aurobindo Pharma receives USFDA nod for Quinapril tabletsAurobindo Pharma said it has received final approval from the US health regulator to manufacture and market Quinapril tablets in the Americ...
- Aurobindo gets USFDA nod for Hydrochlorothiazide tablets
In a statement, Aurobindo said the drug, a generic equivalent to Novartis Pharmaceuticals Corp's Diovan HCT Tablets, is ready for launch.
- Aurobindo Pharma gets USFDA nod for anti-hypertension medicine
Aurobindo Pharma today said it has received final approvals from the US health regulator to manufacture and market Amlodipine Besylate and ...
- Aurobindo Pharma gets USFDA nod for Rampiril Capsules
The drug used for the treatment of congestive heart failure & high BP will be available in 1.25mg, 2.5mg, 5mg and 10mg strengths.
- Aurobindo gets USFDA nod for anti-hypertension tablets
Aurobindo Pharma today said it has received the US health regulator's nod to manufacture and market Fosinopril Sodium tablets.
- Sundaram Fin deposit base cross Rs 1000 cr
The fixed deposits of Sundaram Finance, a leading NBFC, have crossed the Rs 1000 crore mark, which is the highest in the five decades old h...
- Sundaram Fin deposit base cross Rs 1000 cr
The fixed deposits of Sundaram Finance, a leading NBFC, have crossed the Rs 1000 crore mark, which is the highest in the five decades old h...
- Aurobindo gets USFDA approval for two generic drugs
Aurobindo Pharma Ltd has received tentative approval form US Food Drug Administration for perindopril erbumine tablets 2mg, 4mg, 8mg and es...